Detalles de la búsqueda
1.
Association of Immune-Related Adverse Events with Pembrolizumab Efficacy in the Treatment of Advanced Urothelial Carcinoma.
Oncology
; 98(4): 237-242, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-31935736
2.
Association Between Immune-related Adverse Events and Clinical Outcome Following Nivolumab Treatment in Patients With Metastatic Renal Cell Carcinoma.
In Vivo
; 34(5): 2647-2652, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32871795
Resultados
1 -
2
de 2
1
Próxima >
>>